News by year
Non-english news
News - Greatest Hits!
Below is a selection of the media pieces that best reflect the nature of our work from a scientific, IT and intellectual property perspective.
The Freedom to Innovate: A Privilege or a
Right? (info)
Editorial of The Plant Cell, May 2007
"...efforts to make the claims of patents ... more transparent and
navigable, such as the Patent Lens ...should be supported by all."
Google
is Great, but the Patent Lens is Better
Tech LawForum,
December 14, 2006
"Transparency in patents is a good idea others are
getting into in a big way, but there's still room for mutual improvement."
Patently Transparent (info)
Nature
Biotechnology , May 2006
"The ability to interpret and filter
intellectual property (IP) has never been more important...Cambia's Patent Lens
is a giant leap in the right direction"
Open Source BioTech
Red Herring,
April 11, 2006
"Patent transparency is the lifeblood of the new open
source." In a feature edition, renowned IT mag Red Herring focuses on Cambia's
role in pushing the boundaries of the biotech industry.
Navigating the Future(s) of Biotech Intellectual
Property
Nature Biotechnology, March 8, 2006
What
impact is open source having on the biotech IP system?
Open Source Biotech: Science as a Tool for Social
Justice
Genome Canada's Bulletin, July 1, 2005
"If
you can't win the game, then change the rules. That could be the mantra of
Cambia..."
Open-Source Practices for Biotechnology'
New York Times, February 10, 2005
A profile of BIOS including a
discussion of the Nature publication.
Gene Transfer to Plants by Divers Species of Bacteria
Nature, February 10, 2005
Cambia researchers publish a
groundbreaking study demonstrating the viability of non-Agrobacterium bacteria
in plant gene transfer.
2006 News Items
Fortune Magazine: Tools For Better Living
Tools for Better Living, AustraliaDecember 11, 2006
The Basement Interviews
Open and Shut by Richard Poynder, USASeptember 22, 2006
Richard Jefferson, founder and CEO of CAMBIA, and 'leading light' of the Biological Open Source Movement, talks to Richard Poynder
Science as Social Enterprise: The CAMBIA BiOS Initiative
Innovation, USASeptember 1, 2006
"Extraordinary efficiencies occur when the tools of innovation are shared ... and are low or no-cost."
AVIAN INFLUENZA: Pushed by an Outsider, Scientists Call for Global Plan to Share Flu Data
Science Magazine, USAAugust 25, 2006
CAMBIA to lend expertise in life science collaboration to the scientists from over 30 countries who have announced plans to share data on avian influenza.
Open Science: Open Source Licenses in Scientific Research
North Carolina Journal of Law & Technology, USAJuly 3, 2006
"Another success story in open science is CAMBIA...attempting to solve many of the problems open science has faced by the judicious use of IP work arounds...."
Out to break biotech's IP stranglehold
Science|Business, USAJune 7, 2006
Biological Open Source "would enable both commercial and non-profit entities to pool ideas and apply innovations more broadly, and more cheaply"
WIPO support for BIOS
Letter, WIPOMay 23, 2006
WIPO (the World Intellectual Property Organization) extends support to the BIOS Initiative.
Patent Transparency Critical for Innovation
CAMBIA Media Release, AustraliaApril 13, 2006
Open Source BioTech
Red Herring, USAApril 11, 2006
"Patent transparency is the lifeblood of the new open source." In a feature edition, renowned IT mag Red Herring focuses on CAMBIA's role in pushing the boundaries of the biotech industry.
Controls over Plant Genetic Resources
Nature Reviews Genetics, USAApril 1, 2006
Strategies from the patent system that keep technologies available to farmers could be adapted and built into biodiversity laws to suit the exchange of genetic resources. These could include open-source strategies as initiated by CAMBIA's BiOS Initiative.
Open, but not as usual
The EconomistMarch 16, 2006
“Open-source” models move beyond software into other businesses. The way open source projects organise themselves is critical to ensuring their quality. CAMBIA, Toyota and Sun are cited.
Navigating the Future(s) of Biotech Intellectual Property
Nature Biotechnology, USAMarch 8, 2006
What impact is open source having on the biotech IP system?
Who's who in biotech
Nature Biotechnology, USAMarch 1, 2006
Nature Biotechnology's readers select some of biotech's most remarkable and influential personalities from the past 10 years. Richard Jefferson makes the shortlist.
Bayh-Dole: if we knew then what we know now
Nature Biotechnology, USAMarch 1, 2006
More than 25 years after the US Bayh-Dole Act was passed to encourage technology transfer from universities, is it time to reexamine and revamp this key legislation?



There are no comments.